MoneyWorks4Me

Dr Reddys Laboratories board recommends final dividend

19 May 2022 Evaluate

Dr Reddys Laboratories has informed that the Board of Directors of the Company at its meeting held on May 19, 2022, has recommended a final dividend of Rs 30 (600%) per equity share of Rs 5 each for the financial year 2021-22. The dividend will be paid on or after five days from the date of declaration of the final dividend by the shareholders at the 38th Annual General Meeting (AGM).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.00
Dr. Reddys Labs. 1149.75
Cipla 1361.00
Lupin 2055.35
Zydus Lifesciences 1099.00
View more..